カテゴリー： QYResearch, 世界

世界の胃腸運動障害薬市場 2019年

【英語タイトル】Global Gastric Motility Disorder Drug Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X08373）・商品コード：DATA909X08373
・発行会社（調査会社）：QYResearch
・発行日：2019年11月15日（※2024年版があります。お問い合わせください）
・ページ数：102
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、胃腸運動障害薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ベルセトラグ、イパモレリン、TD-8954、その他に、用途別には、病院、診療所、家庭用にセグメント区分し、胃腸運動障害薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・胃腸運動障害薬の世界市場概要
・胃腸運動障害薬の製造コスト構成分析
・胃腸運動障害薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・胃腸運動障害薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・胃腸運動障害薬のセグメント分析（種類別）
（ベルセトラグ、イパモレリン、TD-8954、その他）
・胃腸運動障害薬のセグメント分析（用途別）
（病院、診療所、家庭用）
・胃腸運動障害薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Theravance, Inc.、Helsinn Healthcare S.A.、Concert Pharmaceuticals, Inc.、Targacept, Inc.、ChironWells GmbH、）
・胃腸運動障害薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Gastric Motility Disorder Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Gastric Motility Disorder Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Gastric Motility Disorder Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Gastric Motility Disorder Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Gastric Motility Disorder Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Theravance, Inc.
Helsinn Healthcare S.A.
Concert Pharmaceuticals, Inc.
Targacept, Inc.
ChironWells GmbH
…

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Velusetrag
Ipamorelin
TD-8954
Others

Segment by Application
Hospital
Clinic
Home Use

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Gastric Motility Disorder Drug
1.1 Definition of Gastric Motility Disorder Drug
1.2 Gastric Motility Disorder Drug Segment by Type
1.2.1 Global Gastric Motility Disorder Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Velusetrag
1.2.3 Ipamorelin
1.2.4 TD-8954
1.2.5 Others
1.3 Gastric Motility Disorder Drug Segment by Applications
1.3.1 Global Gastric Motility Disorder Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home Use
1.4 Global Gastric Motility Disorder Drug Overall Market
1.4.1 Global Gastric Motility Disorder Drug Revenue (2014-2025)
1.4.2 Global Gastric Motility Disorder Drug Production (2014-2025)
1.4.3 North America Gastric Motility Disorder Drug Status and Prospect (2014-2025)
1.4.4 Europe Gastric Motility Disorder Drug Status and Prospect (2014-2025)
1.4.5 China Gastric Motility Disorder Drug Status and Prospect (2014-2025)
1.4.6 Japan Gastric Motility Disorder Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Gastric Motility Disorder Drug Status and Prospect (2014-2025)
1.4.8 India Gastric Motility Disorder Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Gastric Motility Disorder Drug
2.3 Manufacturing Process Analysis of Gastric Motility Disorder Drug
2.4 Industry Chain Structure of Gastric Motility Disorder Drug

3 Development and Manufacturing Plants Analysis of Gastric Motility Disorder Drug
3.1 Capacity and Commercial Production Date
3.2 Global Gastric Motility Disorder Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Gastric Motility Disorder Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Gastric Motility Disorder Drug Production and Capacity Analysis
4.2 Gastric Motility Disorder Drug Revenue Analysis
4.3 Gastric Motility Disorder Drug Price Analysis
4.4 Market Concentration Degree

5 Gastric Motility Disorder Drug Regional Market Analysis
5.1 Gastric Motility Disorder Drug Production by Regions
5.1.1 Global Gastric Motility Disorder Drug Production by Regions
5.1.2 Global Gastric Motility Disorder Drug Revenue by Regions
5.2 Gastric Motility Disorder Drug Consumption by Regions
5.3 North America Gastric Motility Disorder Drug Market Analysis
5.3.1 North America Gastric Motility Disorder Drug Production
5.3.2 North America Gastric Motility Disorder Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Gastric Motility Disorder Drug Import and Export
5.4 Europe Gastric Motility Disorder Drug Market Analysis
5.4.1 Europe Gastric Motility Disorder Drug Production
5.4.2 Europe Gastric Motility Disorder Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Gastric Motility Disorder Drug Import and Export
5.5 China Gastric Motility Disorder Drug Market Analysis
5.5.1 China Gastric Motility Disorder Drug Production
5.5.2 China Gastric Motility Disorder Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Gastric Motility Disorder Drug Import and Export
5.6 Japan Gastric Motility Disorder Drug Market Analysis
5.6.1 Japan Gastric Motility Disorder Drug Production
5.6.2 Japan Gastric Motility Disorder Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Gastric Motility Disorder Drug Import and Export
5.7 Southeast Asia Gastric Motility Disorder Drug Market Analysis
5.7.1 Southeast Asia Gastric Motility Disorder Drug Production
5.7.2 Southeast Asia Gastric Motility Disorder Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Gastric Motility Disorder Drug Import and Export
5.8 India Gastric Motility Disorder Drug Market Analysis
5.8.1 India Gastric Motility Disorder Drug Production
5.8.2 India Gastric Motility Disorder Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Gastric Motility Disorder Drug Import and Export

6 Gastric Motility Disorder Drug Segment Market Analysis (by Type)
6.1 Global Gastric Motility Disorder Drug Production by Type
6.2 Global Gastric Motility Disorder Drug Revenue by Type
6.3 Gastric Motility Disorder Drug Price by Type

7 Gastric Motility Disorder Drug Segment Market Analysis (by Application)
7.1 Global Gastric Motility Disorder Drug Consumption by Application
7.2 Global Gastric Motility Disorder Drug Consumption Market Share by Application (2014-2019)

8 Gastric Motility Disorder Drug Major Manufacturers Analysis
8.1 Theravance, Inc.
8.1.1 Theravance, Inc. Gastric Motility Disorder Drug Production Sites and Area Served
8.1.2 Theravance, Inc. Product Introduction, Application and Specification
8.1.3 Theravance, Inc. Gastric Motility Disorder Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Helsinn Healthcare S.A.
8.2.1 Helsinn Healthcare S.A. Gastric Motility Disorder Drug Production Sites and Area Served
8.2.2 Helsinn Healthcare S.A. Product Introduction, Application and Specification
8.2.3 Helsinn Healthcare S.A. Gastric Motility Disorder Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Concert Pharmaceuticals, Inc.
8.3.1 Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Production Sites and Area Served
8.3.2 Concert Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.3.3 Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Targacept, Inc.
8.4.1 Targacept, Inc. Gastric Motility Disorder Drug Production Sites and Area Served
8.4.2 Targacept, Inc. Product Introduction, Application and Specification
8.4.3 Targacept, Inc. Gastric Motility Disorder Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 ChironWells GmbH
8.5.1 ChironWells GmbH Gastric Motility Disorder Drug Production Sites and Area Served
8.5.2 ChironWells GmbH Product Introduction, Application and Specification
8.5.3 ChironWells GmbH Gastric Motility Disorder Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served

9 Development Trend of Analysis of Gastric Motility Disorder Drug Market
9.1 Global Gastric Motility Disorder Drug Market Trend Analysis
9.1.1 Global Gastric Motility Disorder Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Gastric Motility Disorder Drug Regional Market Trend
9.2.1 North America Gastric Motility Disorder Drug Forecast 2019-2025
9.2.2 Europe Gastric Motility Disorder Drug Forecast 2019-2025
9.2.3 China Gastric Motility Disorder Drug Forecast 2019-2025
9.2.4 Japan Gastric Motility Disorder Drug Forecast 2019-2025
9.2.5 Southeast Asia Gastric Motility Disorder Drug Forecast 2019-2025
9.2.6 India Gastric Motility Disorder Drug Forecast 2019-2025
9.3 Gastric Motility Disorder Drug Market Trend (Product Type)
9.4 Gastric Motility Disorder Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Gastric Motility Disorder Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Gastric Motility Disorder Drug
Table Global Gastric Motility Disorder Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Gastric Motility Disorder Drug Production Market Share by Types in 2018
Figure Velusetrag Product Picture
Figure Ipamorelin Product Picture
Figure TD-8954 Product Picture
Figure Others Product Picture
Table Global Gastric Motility Disorder Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Gastric Motility Disorder Drug Consumption Market Share by Applications in 2018
Figure Hospital
Figure Clinic
Figure Home Use
Figure Global Gastric Motility Disorder Drug Revenue (Million USD) (2014-2025)
Figure Global Gastric Motility Disorder Drug Production (K Pcs) (2014-2025)
Figure North America Gastric Motility Disorder Drug Market Size (Million USD) (2014-2025)
Figure Europe Gastric Motility Disorder Drug Market Size (Million USD) (2014-2025)
Figure China Gastric Motility Disorder Drug Market Size (Million USD) (2014-2025)
Figure Japan Gastric Motility Disorder Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Gastric Motility Disorder Drug Market Size (Million USD) (2014-2025)
Figure India Gastric Motility Disorder Drug Market Size (Million USD) (2014-2025)
Table Gastric Motility Disorder Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Gastric Motility Disorder Drug in 2018
Figure Manufacturing Process Analysis of Gastric Motility Disorder Drug
Figure Industry Chain Structure of Gastric Motility Disorder Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Gastric Motility Disorder Drug Manufacturing Plants Distribution
Table Gastric Motility Disorder Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Gastric Motility Disorder Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Gastric Motility Disorder Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Gastric Motility Disorder Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Gastric Motility Disorder Drug Production Share by Manufacturers in 2018
Table Gastric Motility Disorder Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Gastric Motility Disorder Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Gastric Motility Disorder Drug Revenue Share by Manufacturers in 2018
Table Gastric Motility Disorder Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Gastric Motility Disorder Drug Production by Regions 2014-2019 (K Pcs)
Table Global Gastric Motility Disorder Drug Production Market Share by Regions 2014-2019
Figure Global Gastric Motility Disorder Drug Production Market Share by Regions in 2018
Table Global Gastric Motility Disorder Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Gastric Motility Disorder Drug Revenue Market Share by Regions 2014-2019
Figure Global Gastric Motility Disorder Drug Revenue Market Share by Regions in 2018
Table Global Gastric Motility Disorder Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Gastric Motility Disorder Drug Consumption Market Share by Regions 2014-2019
Figure North America Gastric Motility Disorder Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Gastric Motility Disorder Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Gastric Motility Disorder Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Gastric Motility Disorder Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Gastric Motility Disorder Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Gastric Motility Disorder Drug Production, Consumption Import and Export (K Pcs)
Figure China Gastric Motility Disorder Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Gastric Motility Disorder Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Gastric Motility Disorder Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Gastric Motility Disorder Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Gastric Motility Disorder Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Gastric Motility Disorder Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Gastric Motility Disorder Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Gastric Motility Disorder Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Gastric Motility Disorder Drug Production, Consumption Import and Export (K Pcs)
Figure India Gastric Motility Disorder Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Gastric Motility Disorder Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Gastric Motility Disorder Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Gastric Motility Disorder Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Gastric Motility Disorder Drug Market Share by Application (2014-2019)
Table Theravance, Inc. Gastric Motility Disorder Drug Production Sites and Area Served
Table Theravance, Inc. Gastric Motility Disorder Drug Product Introduction, Application and Specification
Table Theravance, Inc. Gastric Motility Disorder Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Theravance, Inc. Gastric Motility Disorder Drug Production Growth Rate (2014-2019)
Table Theravance, Inc. Gastric Motility Disorder Drug Production Market Share (2014-2019)
Figure Theravance, Inc. Gastric Motility Disorder Drug Revenue Market Share (2014-2019)
Table Theravance, Inc. Gastric Motility Disorder Drug Main Business and Markets Served
Table Helsinn Healthcare S.A. Gastric Motility Disorder Drug Production Sites and Area Served
Table Helsinn Healthcare S.A. Gastric Motility Disorder Drug Product Introduction, Application and Specification
Table Helsinn Healthcare S.A. Gastric Motility Disorder Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Helsinn Healthcare S.A. Gastric Motility Disorder Drug Production Growth Rate (2014-2019)
Table Helsinn Healthcare S.A. Gastric Motility Disorder Drug Production Market Share (2014-2019)
Figure Helsinn Healthcare S.A. Gastric Motility Disorder Drug Revenue Market Share (2014-2019)
Table Helsinn Healthcare S.A. Gastric Motility Disorder Drug Main Business and Markets Served
Table Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Production Sites and Area Served
Table Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Product Introduction, Application and Specification
Table Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Production Growth Rate (2014-2019)
Table Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Production Market Share (2014-2019)
Figure Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Revenue Market Share (2014-2019)
Table Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Main Business and Markets Served
Table Targacept, Inc. Gastric Motility Disorder Drug Production Sites and Area Served
Table Targacept, Inc. Gastric Motility Disorder Drug Product Introduction, Application and Specification
Table Targacept, Inc. Gastric Motility Disorder Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Targacept, Inc. Gastric Motility Disorder Drug Production Growth Rate (2014-2019)
Table Targacept, Inc. Gastric Motility Disorder Drug Production Market Share (2014-2019)
Figure Targacept, Inc. Gastric Motility Disorder Drug Revenue Market Share (2014-2019)
Table Targacept, Inc. Gastric Motility Disorder Drug Main Business and Markets Served
Table ChironWells GmbH Gastric Motility Disorder Drug Production Sites and Area Served
Table ChironWells GmbH Gastric Motility Disorder Drug Product Introduction, Application and Specification
Table ChironWells GmbH Gastric Motility Disorder Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table ChironWells GmbH Gastric Motility Disorder Drug Production Growth Rate (2014-2019)
Table ChironWells GmbH Gastric Motility Disorder Drug Production Market Share (2014-2019)
Figure ChironWells GmbH Gastric Motility Disorder Drug Revenue Market Share (2014-2019)
Table ChironWells GmbH Gastric Motility Disorder Drug Main Business and Markets Served
Figure Global Gastric Motility Disorder Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Gastric Motility Disorder Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Gastric Motility Disorder Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Gastric Motility Disorder Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Gastric Motility Disorder Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Gastric Motility Disorder Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Gastric Motility Disorder Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Gastric Motility Disorder Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Gastric Motility Disorder Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Gastric Motility Disorder Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Gastric Motility Disorder Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Gastric Motility Disorder Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Gastric Motility Disorder Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Gastric Motility Disorder Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Gastric Motility Disorder Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Gastric Motility Disorder Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Gastric Motility Disorder Drug by Application (2019-2025)
Table Gastric Motility Disorder Drug Distributors List
Table Gastric Motility Disorder Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Theravance, Inc.、Helsinn Healthcare S.A.、Concert Pharmaceuticals, Inc.、Targacept, Inc.、ChironWells GmbH、

★調査レポート[世界の胃腸運動障害薬市場 2019年] (コード：DATA909X08373)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の胃腸運動障害薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の甲状腺ホルモン障害薬市場 2019年
    DATA909X16560 / QYResearch / 2019年11月22日 / ※本調査レポートは、甲状腺ホルモン障害薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、注射剤、経口剤、その他に、用途別には、病院、クリニック、医療センター、その他にセグメント区分し、甲状腺ホルモン障害薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・甲状腺ホルモン障害薬の世界市場概要 ・甲状腺ホルモン障害薬の製造コスト構成分析 ・甲状腺ホルモン障害薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・甲状腺ホルモン障害薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・甲状腺ホルモン障害薬のセグメント分析（種類別） （注射剤、経口剤、その他）...The global Thyroid Hormone Disorder Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Thyroid Hormone Disorder Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Thyroid Hormone Disorder Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Thyroid Hormone Disorder Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の注意欠陥多動性障害(ADHD)薬市場 2019年
    DATA909X03802 / QYResearch / 2019年11月15日 / ※本調査レポートは、注意欠陥多動性障害(ADHD)薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、興奮剤、非興奮剤に、用途別には、小児、青年、成人にセグメント区分し、注意欠陥多動性障害(ADHD)薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・注意欠陥多動性障害(ADHD)薬の世界市場概要 ・注意欠陥多動性障害(ADHD)薬の製造コスト構成分析 ・注意欠陥多動性障害(ADHD)薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・注意欠陥多動性障害(ADHD)薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・注意欠陥多動性障害(ADHD)薬のセグメント分析（種類別） （興奮剤、非興奮剤）...The global Attention Deficit Hyperactivity Disorder (ADHD) Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Attention Deficit Hyperactivity Disorder (ADHD) Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Attention Deficit Hyperactivity Disorder (ADHD) Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Attention Deficit Hyperactivity Disorder (ADHD) Drug in North America, Europe, China,...
  • 世界の胃粘膜保護剤市場 2019年
    DATA909X08374 / QYResearch / 2019年11月15日 / ※本調査レポートは、胃粘膜保護剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、タブレット、チュアブル、注射可能に、用途別には、病院、研究室、その他にセグメント区分し、胃粘膜保護剤の世界市場を分析しました。 ・エグゼクティブ・サマリー ・胃粘膜保護剤の世界市場概要 ・胃粘膜保護剤の製造コスト構成分析 ・胃粘膜保護剤の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・胃粘膜保護剤の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・胃粘膜保護剤のセグメント分析（種類別） （タブレット、チュアブル、注射可能）...The global Gastric Mucosal Protective Agent market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Gastric Mucosal Protective Agent volume and value at global level, regional level and company level. From a global perspective, this report represents overall Gastric Mucosal Protective Agent market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Gastric Mucosal Protective Agent in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...

    • ◆H&Iグローバルリサーチのお客様（例）◆